Oncternal Therapeutics, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Oncternal Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -136 %, a 79.9% decline year-over-year.
  • Oncternal Therapeutics, Inc. annual Return On Equity for 2023 was -95.9 %, a 53.9% decline from 2022.
  • Oncternal Therapeutics, Inc. annual Return On Equity for 2022 was -62.3 %, a 95.5% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Return On Equity for 2021 was -31.9 %, a 31.3% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -95.9 -33.6 -53.9% Jan 1, 2023 Dec 31, 2023
2022 -62.3 -30.4 -95.5% Jan 1, 2022 Dec 31, 2022
2021 -31.9 +14.5 +31.3% Jan 1, 2021 Dec 31, 2021
2020 -46.4 +535 +92% Jan 1, 2020 Dec 31, 2020
2019 -581 -605 -2540% Jan 1, 2019 Dec 31, 2019
2018 23.8 +289 Jan 1, 2018 Dec 31, 2018
2017 -265 -170 -178% Jan 1, 2017 Dec 31, 2017
2016 -95.3 -905 -112% Jan 1, 2016 Dec 31, 2016
2015 809 +1.04K Jan 1, 2015 Dec 31, 2015
2014 -229 -38.6 -20.3% Jan 1, 2014 Dec 31, 2014
2013 -190 -141 -289% Jan 1, 2013 Dec 31, 2013
2012 -49 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.